JW Pharmaceutical Corporation

Symbol: 001060.KS

KSC

23200

KRW

company-market-status

  • 14.7111

    P/E ratio

  • 0.1627

    PEG ratio

  • 523.29B

    Mrk Cap

  • 0.02%

    Div Yield

JW Pharmaceutical Corporation (001060-KS) Stock Split, History Data

Оборотен капитал

Всички числа в милиони

202220212020201920182017
Парични средства и инвестиции33897.9333366.4810451.3441864.2530948.4232096.84
Приемници0.000.000.000.000.000.00
Инвентарна книга111668.43102527.60101197.7990442.49101367.13106626.80
Други1963.725417.8310096.2713737.34241594.53272643.30
Общо текущи активи425457.06366451.50299328.71335057.45373910.08411366.93
Acc Payable82907.8851642.8547885.3945087.2244464.6159586.12
Краткосрочен дълг207693.01123074.57107315.68155880.77128030.97176857.30
Други текущи пасиви89530.21107960.1479546.5677015.3847181.0733956.63
Текущи пасиви380131.10282677.56234747.63277983.38228368.45274537.16

Капиталова структура

Всички числа в милиони

Общо активи

671086,33 щ.д.

Общо активи

671086327000,00 щ.д.

Общо задължения

437385,40 щ.д.

Общо задължения

437385404000,00 щ.д.

Дългосрочен дълг

29555,72 щ.д.

Дългосрочен дълг

29555722400,00 щ.д.

Парични средства и екви

23568,94 щ.д.

Парични средства и екви

23568940960,00 щ.д.

Goodwill

3463,45 щ.д.

Goodwill

3463449000,00 щ.д.

Неразпределена печалба

95842,33 щ.д.

Неразпределена печалба

95842325920,00 щ.д.

Обикновени акции

33578,95 щ.д.

Обикновени акции

33578950000,00 щ.д.

Стойност на предприятието

0,00 щ.д.

Дивиденти за маса

Подзаглавие на таблицата Dividends

ГодиниQ1Q2Q3Q4Общо
20070.0000.0000.000180.100180.100
20100.0000.0000.000191.068191.068
20110.0000.0000.000137.760137.760
20120.0000.0000.00090.40590.405
20130.0000.0000.00090.40590.405
20140.0000.0000.00094.92594.925
20150.0000.0000.000119.606119.606
20160.0000.0000.000209.310209.310
20170.0000.0000.000239.543239.543
20180.0000.0000.000288.758288.758
20190.0000.0000.000297.421297.421
20200.0000.0000.000297.421297.421
20210.0000.0000.000315.534315.534
20220.0000.0000.000364.078364.078

Печалба на акция

Подзаглавие "Доходи на акция

ГодиниQ1Q2Q3Q4Общо
20070.0000.0000.000180.100180.100
20100.0000.0000.000191.068191.068
20110.0000.0000.000137.760137.760
20120.0000.0000.00090.40590.405
20130.0000.0000.00090.40590.405
20140.0000.0000.00094.92594.925
20150.0000.0000.000119.606119.606
20160.0000.0000.000209.310209.310
20170.0000.0000.000239.543239.543
20180.0000.0000.000288.758288.758
20190.0000.0000.000297.421297.421
20200.0000.0000.000297.421297.421
20210.0000.0000.000315.534315.534
20220.0000.0000.000364.078364.078
Подобни запаси
Може да се интересувате и от
CHSYF
China Medical System Holdings Limited.
1.381 USD
PNK
SRUTF
Sproutly Canada Inc..
0.0001 USD
PNK
RMTI
Rockwell Medical, Inc..
4.33 USD
NASDAQ
BOD.AX
Bod Science Limited.
0.048 AUD
ASX
AVCN.TO
Avicanna Inc..
0.305 CAD
TSX
PDPL.NS
Parenteral Drugs (India) Limited.
4 INR
NSE
SCYX
SCYNEXIS, Inc..
2.59 USD
NASDAQ
001360.KS
SAMSUNG PHARM. Co., LTD..
3240 KRW
KSC
RDHL
RedHill Biopharma Ltd..
1.93 USD
NASDAQ

Frequently Asked Question

Why is your stock tool better than competitors?

Numfin provides most features for free and gives you accurate and expert data about public companies. We also offer unique features like AI copilot that are not found on other platforms

Can I trust the data on your website and where do they come from?

Absolutely. We receive the data from our partners and other official sources, such as popular stock exchanges (NASDAQ, NYSE, and others), SEC.gov, and other official platforms. Our data provider, FinancialModeling, also provides information for portals like Moody's, Harvard, Chevron, and others. All this proves the accuracy and authority of the information.

Who creates the content on your website and is it approved by experts in finance and investing?

All financial data is received from our data provider and then verified by industry experts. Additionally, we use various AI tools like ChatGPT to present content in a user-friendly and well-structured manner.

What problem does your tool solve? Who is the target audience for your tool

Our main goal is to present accurate and expert information about public companies in a structured manner. We work with investors and financial professionals who have a long-term outlook. Our community consists of private investors, business owners, stock analysts, fund managers, and people who are interested in investing.

Why did you decide to create your tool?

While managing our own money, we searched for the best analytical tool to help us better analyze public companies. Most websites that provided analytics for professional investors were expensive, and the cheap tools were either limited in functionality or lacked valuable company data. Even worse, some of them presented incorrect numbers. As a result, we combined our experience in business, IT, and finance to create the most affordable and useful solution for investors and anyone interested in finance and stock analysis.

What is the difference between free and paid options? Should I buy Pro version from start or it's ok to have a free version?

Most features on our website are free so that many people can use it to analyze companies on the world's top stock exchanges. However, some features, such as our artificial intelligence chat, advanced analytics, filters, and storing of vast historical data, require additional servers from our end. Therefore, we rely on your support to keep this amazing project running. If you would like to experience the full potential of our service, we strongly recommend that you purchase the PRO version, which comes with a 30-day money-back guarantee

Who is your team and do they have enough experience?

You can read about our team here, or you can contact us at [email protected] for more information.